Valerie Cristina

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


23 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 |
 
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.
Bandiera C., Cardoso E., Locatelli I., Zaman K., Diciolla A., Digklia A., Stravodimou A., Cristina V., Aedo-Lopez V., Dolcan A. et al., 2024. PloS one, 19 (6) pp. e0304573. Peer-reviewed.
Cancers des glandes salivaires : nouvelles approches thérapeutiques [Salivary gland cancer: new therapeutic approaches]
Herrera Gomez R.G., Mederos N., Szturz P., Degrauwe N., Jankovic J., Cristina V., 2023/05/17. Revue medicale suisse, 19 (827) pp. 958-963. Peer-reviewed.
 
Oncologie : ce qui a changé en 2022 [Oncology: what's new in 2022]
Nguyen-Ngoc T., Abdelhamid K., Degrauwe N., Galland S., Serena A., Christofis M., Mederos N., Bouchaab H., Diciolla A., Dris N. et al., 2023/01/18. Revue medicale suisse, 19 (N° 809-10) pp. 52-57. Peer-reviewed.
 
An interprofessional medication adherence program to optimize adherence to oral anticancer therapies: a randomized-controlled trial
Bandiera C., Cardoso E., Locatelli I., Digklia A., Zaman K., Diciolla A., Cristina V., Stravodimou A., Lopez V.A., Dolcan A. et al., 2023., 26th International Society for Medication Adherence (ESPACOMP) Conference p. 269 dans International Journal of Clinical Pharmacy. Peer-reviewed.
Oncologie [2021 Oncology update]
Meyer M.L., Chrysou K., Stamatiou A., Gilabert M., Herrera Gomez R.G., Latifyan S., Masmoudi S., Mederos N., Perrinjaquet C., Berthold D. et al., 2022/02/02. Revue medicale suisse, 18 (767) pp. 182-186. Peer-reviewed.
Papillary Thyroid Carcinoma with Desmoid-Type Fibromatosis: Review of Published Cases.
Roukain A., La Rosa S., Bongiovanni M., Nicod Lalonde M., Cristina V., Montemurro M., Cochet S., Luquain A., Kopp P.A., Sykiotis G.P., 2021/09/06. Cancers, 13 (17) p. 4482. Peer-reviewed.
Carcinome anaplasique de la thyroïde : nouvelles approches thérapeutiques [Anaplastic thyroid carcinoma : new therapeutic approaches]
Stamatiou A., Herrera-Gómez R.G., Szturz P., Bisig B., Romano E., Sykiotis G., Gorostidi F., La Rosa S., Kopp P., Cristina V., 2021/05/19. Revue medicale suisse, 17 (739) pp. 962-966. Peer-reviewed.
Oncologie [2020 oncology update]
Dei Tos G., Galli Vareia I., Huber A., Wolf B., Diciolla A., Herrera Gomez R.G., Wagner D., Digklia A., Bouchaab H., Cristina V. et al., 2021/01/27. Revue medicale suisse, 17 (723) pp. 201-205. Peer-reviewed.
Optimizing oral targeted anticancer therapies study for patients with solid cancer: Protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data.
Bandiera C., Cardoso E., Locatelli I., Digklia A., Zaman K., Diciolla A., Cristina V., Stravodimou A., Lopez V.A., Dolcan A. et al., 2021. JMIR Research Protocols, 10 (6) pp. e30090. Peer-reviewed.
 
Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Le Tourneau C., Tao Y., Gomez-Roca C., Cristina V., Borcoman E., Deutsch E., Bahleda R., Calugaru V., Modesto A., Rouits E. et al., 2020/12/15. Clinical cancer research, 26 (24) pp. 6429-6436. Peer-reviewed.
 
Gender medicine and oncology: report and consensus of an ESMO workshop.
Wagner A.D., Oertelt-Prigione S., Adjei A., Buclin T., Cristina V., Csajka C., Coukos G., Dafni U., Dotto G.P., Ducreux M. et al., 2019/12/01. Annals of oncology, 30 (12) pp. 1914-1924. Peer-reviewed.
 
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B., Harrington K.J., Greil R., Soulières D., Tahara M., de Castro G., Psyrri A., Basté N., Neupane P., Bratland Å. et al., 2019/11/23. Lancet, 394 (10212) pp. 1915-1928. Peer-reviewed.
Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma.
Cristina V., Herrera-Gómez R.G., Szturz P., Espeli V., Siano M., 2019/10/30. International journal of molecular sciences, 20 (21). Peer-reviewed.
 
F-18-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.
Jreige M., Letovanec I., Chaba K., Renaud S., Rusakiewicz S., Cristina V., Peters S., Krueger T., de Leval L., Kandalaft L.E. et al., 2019/08. European journal of nuclear medicine and molecular imaging, 46 (9) pp. 1859-1868. Peer-reviewed.
Inappropriate Grading of Adverse Events in Cancer Clinical Trials-Reply.
Cristina V., Mauer M., Wagner A.D., 2019/02/01. JAMA oncology, 5 (2) pp. 269-270. Peer-reviewed.
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.
Szturz P., Cristina V., Herrera Gómez R.G., Bourhis J., Simon C., Vermorken J.B., 2019. Frontiers in oncology, 9 p. 464. Peer-reviewed.
 
Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group.
Cristina V., Mahachie J., Mauer M., Buclin T., Van Cutsem E., Roth A., Wagner A.D., 2018/07/01. JAMA oncology, 4 (7) pp. 1003-1006. Peer-reviewed.
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program.
Balmelli C., Railic N., Siano M., Feuerlein K., Cathomas R., Cristina V., Güthner C., Zimmermann S., Weidner S., Pless M. et al., 2018. Journal of Cancer, 9 (2) pp. 250-255. Peer-reviewed.
 
Cancers de la sphère ORL : l’immunothérapie donne de la voix ! [Head and neck cancer : promising results of immunotherapy]
Sivade A., Bensaid D., Monnier Y., Shabafrouz K., Bouchaab H., Cristina V., 2017/05/17. Revue medicale suisse, 13 (563) pp. 1029-1031. Peer-reviewed.
 
Carcinome hépatocellulaire avancé: importance des essais thérapeutiques [Advanced hepatocellular carcinoma: importance of clinical trials]
Aedo V., Cristina V., Raymond E., Faivre S., 2015/05/20. Revue medicale suisse, 11 (475) pp. 1149-1151. Peer-reviewed.
 
Nouveautés et perspectives dans la prise en charge des cancers colorectaux et gastriques avancés [News and perspectives in the treatment of advanced gastric and colorectal cancers].
Diciolla A., Cristina V., De Micheli R., Digklia A., Wagner A.D., 2015. Revue Médicale Suisse, 11 (475) pp. 1122, 1124-1122, 1126. Peer-reviewed.
 
Traitement des tumeurs maligne du foie par radiologie interventionnelle: techniques intra-artérielles [Interventional radiology procedures for malignancies of the liver treatment: Intraarterial procedures].
Cristina V., Pracht M., Lachenal Y., Adib S., Boubaker A., Prior J., Denys A., Wagner A.D., Bize P., 2014/05. Revue Médicale Suisse, 10 (431) pp. 1130-2, 1134-5. Peer-reviewed.
 
Traitement des tumeurs malignes du foie par radiologie interventionnelle: techniques ablatives [Interventional radiology procedures for malignancies of the liver: ablation procedures].
Cristina V., Pracht M., Lachenal Y., Denys A., Wagner A.D., Bize P., 2014. Revue Médicale Suisse, 10 (431) pp. 1123-1126.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University